Balance Sheet
Cash Flow Statement
Beginning Cash BalanceBeginning Cash BalanceCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in CashChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Free Cash FlowFree Cash FlowLong-Term Debt IssuancesNet Cash FlowNet Cash FlowNet IncomeOther financing activitiesOther financing activitiesShare-based CompensationShare-based CompensationShares IssuedShort-Term Debt issuances
Growth Metrics
Income Statement
Others
Ratios

Healthy Extracts (HYEX) Net Cash Flow (2016 - 2025)

Healthy Extracts filings provide 11 years of Net Cash Flow readings, the most recent being -$42517.0 for Q4 2025.

  • On a quarterly basis, Net Cash Flow fell 465.96% to -$42517.0 in Q4 2025 year-over-year; TTM through Dec 2025 was $34915.0, a 62.29% decrease, with the full-year FY2025 number at $34915.0, down 62.29% from a year prior.
  • Net Cash Flow hit -$42517.0 in Q4 2025 for Healthy Extracts, down from -$11042.0 in the prior quarter.
  • In the past five years, Net Cash Flow ranged from a high of $173731.0 in Q1 2021 to a low of -$171800.0 in Q3 2021.
  • Median Net Cash Flow over the past 5 years was -$727.5 (2022), compared with a mean of $4386.7.
  • Biggest five-year swings in Net Cash Flow: skyrocketed 364.08% in 2021 and later tumbled 465.96% in 2025.
  • Healthy Extracts' Net Cash Flow stood at $106960.0 in 2021, then crashed by 107.7% to -$8233.0 in 2022, then crashed by 227.34% to -$26950.0 in 2023, then soared by 143.11% to $11618.0 in 2024, then tumbled by 465.96% to -$42517.0 in 2025.
  • The last three reported values for Net Cash Flow were -$42517.0 (Q4 2025), -$11042.0 (Q3 2025), and $81696.0 (Q2 2025) per Business Quant data.